TANG CAPITAL PARTNERS LP 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
TANG CAPITAL PARTNERS LP | 1,753,335 2.500% |
-2,584,820 (-59.58%) |
Filing |
| 2023-11-24 1:49 pm Purchase |
2023-11-14 | 13G | Aclaris Therapeutics, Inc. ACRS |
TANG CAPITAL PARTNERS LP | 4,338,155 6.100% |
4,338,155 (New Position) |
Filing |